NIH-funded research P01 program project

Early-Phase Psychosis: Practice-Based Research to Improve Treatment Outcomes

Funded at Feinstein Institute for Medical Research · NIH-11362312 · Data updated 2026-11-12

A coordinated effort to improve care for people experiencing first-episode psychosis by using learning-health-system tools and real-world clinics.

More Psychosis research and trials

Quick facts

Grant typeP01 program project
Study typeNIH-funded research
Funding institutionFeinstein Institute for Medical Research
NIH-funded
Lab location1 site (Manhasset, United States)
Project startJune 2, 2025
Project endMay 31, 2030
Funding year2026
Award (this year)$1,503,322
NIH project number5P01MH139136-02
Project IDNIH-11362312 on NIH RePORTER

Who could benefit from this research

Could help

Individuals experiencing a first episode of psychosis who are treated in community clinics using the NAVIGATE model.

Less likely to help

Patients not enrolled in NAVIGATE-trained clinics or those outside participating sites may not benefit directly.

What this research studies

This grant builds on NAVIGATE CSC care models for first-episode psychosis and uses an ESPRITO EPINET framework to enroll thousands of participants across diverse community settings. It emphasizes data-driven care, measurement-based practices, and enhanced dashboards to help clinics improve treatment outcomes. The project supports ongoing training for clinic staff and uses central data management to share CAB assessments with a coordinating center. The goal is to refine and scale practical, real-world strategies that improve recovery and functioning for patients in varied communities.

Why it matters

Potential benefit: If successful, patients with first-episode psychosis could receive more timely, personalized care and better overall outcomes through improved, data-guided treatment in real-world clinics.

How similar studies have gone: Prior NAVIGATE and EPINET experiences suggest that learning-health-system approaches can improve care delivery and outcomes in FEP settings.

Where this research is happening

  • Feinstein Institute for Medical Research
    Manhasset, United States
    Active

Researchers

  • Principal investigator: Robinson, Delbert G — Feinstein Institute for Medical Research
  • Study coordinator: Robinson, Delbert G

Related research

Other NIH-funded projects on the same topics.

  • Psychosis in diverse settings across the world

    This project studies how psychotic disorders show up and respond to treatment in adults with diverse backgrounds, including populations in Africa, the Caribbean, and other Global South settings.

    NIH research Suny Downstate Medical Center · Brooklyn, United States · NIH-11592428

  • Psychosis in Diverse Settings: Understanding Symptoms and Treatment Across Global South

    A human-facing study will look at how psychotic disorders present and respond to treatment in adults from Africa, the Caribbean, and other Global South settings, using genetic and clinical data.

    NIH research Suny Downstate Medical Center · Brooklyn, United States · NIH-11592427

  • A new online brain-scan-style tool to spot early psychosis risk

    A new online-based set of tasks and a computer model aims to identify people at high risk for developing psychosis earlier and more accurately.

    NIH research Northwestern University · Chicago, United States · NIH-11590585

  • Genetic clues for early-onset psychosis in Latino youth

    This project looks at the genes of young people with early-onset psychosis and compares them with similar youths without psychosis to find genetic factors that contribute to the illness.

    NIH research Boston Children's Hospital · Boston, United States · NIH-11554752

  • Biomarkers to tailor rehab for Veterans with schizophrenia

    A clinician-scientist is developing a brain-based biomarker to guide personalized rehabilitation for Veterans with schizophrenia.

    NIH research VA San Diego Healthcare System · San Diego, United States · NIH-11552825

  • Computational analysis of facial expression in early psychosis

    Aims to develop computer-based measures of facial expression in people at risk for or with schizophrenia to help track symptoms and guide future trials.

    NIH research Icahn School of Medicine at Mount Sinai · New York, United States · NIH-11539126

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.